BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211018
DTEND;VALUE=DATE:20211020
DTSTAMP:20260515T220447
CREATED:20190503T072628Z
LAST-MODIFIED:20210519T083857Z
UID:20546-1634515200-1634687999@www.pharmajournalist.com
SUMMARY:Wearable Injectors and Connected Devices Conference
DESCRIPTION:The latest innovations in digital health and on-body drug delivery for the pharmaceutical industry \nSMi’s 2nd annual Wearable Injectors and Connected Devices Conference will explore real world case studies of on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices with industry case studies from pharma thought leaders. The conference will consider key developments in the wearable injectors field\, including the enhanced demand for on-body injectors and digitalised health as the pandemic highlights the need for self-administered at-home care\, managing sustainability in the field\, and opportunities for development in oncology. \n \nKey regulatory updates including guidance on MDR requirements and the impact of Brexit on data collection will be presented by regulatory experts for a comprehensive outlook of this exciting and ever-growing field\, and the importance of considering human factors in order to enhance the user experience will be presented by industry experts. \nThis two-day agenda offers you peer-to-peer networking with Global Device Development Managers\, Senior Connectivity Engineers\, Leaders in Device Data Generation\, Human Factors Directors and many more. \nWe look forward to welcoming you to the conference in October. \nFor more information and to register: www.wearable-injectors.co.uk/pjwl   \nBENEFITS OF ATTENDING: \n\nGain insight into developments in wearable devices in clinical trials and adapting to decentralised trials during the pandemic\nExplore design strategies for connectivity and digital health with sessions from Novartis and Bayer\nHear key regulatory updates from regulatory and notified bodies including TÜV SÜD\nDiscover advances in device design for large volume delivery via on-body injectors\nExplore and benchmark against industry developments through case studies and real-world examples in device development for on-body injectors\n\nPlus\, two interactive half-day workshops – Wednesday 20th October 2021 \nA: Cross company collaboration to develop digital therapeutic solutions using connected devices\nWorkshop Leader:\nDigby Harris\, Global Procurement Lead – Digital Therapeutics\, AstraZeneca \nB: Optimising Patient Engagement and Creating Novel Company Value through Digital Technologies\nWorkshop Leaders:\nAlex Gilbert\, Digital Medicine\, Huma \nEarly-Bird Rates \n\nBOOK BY JUNE 30TH TO SAVE £200\nBOOK BY AUGUST 31ST TO SAVE £100\n\nSOCIAL MEDIA HANDLES \nTwitter: @SMiPharm #SMiWearables\nLinkedIn: follow our company page – search ‘SMi Pharma’
URL:https://www.pharmajournalist.com/event/wearable-injectors-and-connected-devices-conference/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Limited":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211019
DTEND;VALUE=DATE:20211022
DTSTAMP:20260515T220447
CREATED:20210524T113716Z
LAST-MODIFIED:20210524T113716Z
UID:30317-1634601600-1634860799@www.pharmajournalist.com
SUMMARY:2nd Annual Dry-AMD Therapeutic Development Summit
DESCRIPTION:Returning for its 2nd year as the world’s leading industry forum\, Dry-AMD Therapeutic Development establishes meaningful clinical endpoints using the latest diagnostic imaging techniques to prove therapeutic safety and efficacy in specific patient populations. \nIn the context of unprecedented Phase III progress\, and as new investigational pharmacological agents enter the clinic\, Dry-AMD Therapeutic Development will deliver a greater breadth and depth of technical content than any other meeting in this field with 3 days and 2 tracks of dedicated content. \n \nUniting large pharma\, biotech and academic KOLs with a reimagined agenda\, this year’s meeting devotes specific content to the unique discovery\, pre-clinical\, translational\, clinical development and commercialization challenges encountered within the dry-AMD space. Ensuring that whatever your role in the field\, you will leave with tangible actions to implement into your strategy and pipeline\, to translate the promise of dry AMD therapies into a reality for patients. \nJoin the 200+ expert community\, as they unite under a common goal of accelerating the approval of next generation therapies for this progressive eye disease. \nTo know more about Dry-AMD Therapeutics Summit please click here.
URL:https://www.pharmajournalist.com/event/2nd-annual-dry-amd-therapeutic-development-summit/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR